The numbers of total CAFs and myofibroblastic α-SMA–positive CAFs were increased in patients with metabolic dysfunction–associated steatotic liver disease (MASLD) (Figure 6D). The gene discussed is ACTA1; the disease is metabolic dysfunction-associated steatotic liver disease.